October 27-28, 2015
Santa Clara Convention Center


Evolving State of HealthTech

Anne DeGheest

Founder, Managing Director HealthTech Capital

Speaker Spotlight:
Anne DeGheest. Unicorns vs. Unicorpse = Business Models.

Anne has 25 years investing and mentoring experience with MedStars, and has been a pioneer entrepreneur and investor in the emerging HealthTech sector. Companies in which Anne has been involved have been market changers and have grown to $6 billion market cap. She has startup operating experience as CEO and VP as well as public and private board positions. Anne earned a Master in Business Engineering, Brussels and an MBA, Harvard.


Serial entrepreneurs: secrets to success

Glen Tullman

Chairman and Chief Executive Officer, Livongo Health

Glen Tullman is Chairman and Chief Executive Officer of Livongo Health™. Tullman is also a successful entrepreneur and co-founder and Managing Partner of 7wire Ventures, a Chicago-based investment firm focused on healthcare and education. Tullman most recently served as Chief Executive Officer of Allscripts (NASDAQ: MDRX), the leading global provider of Electronic Health Records, Practice Management and Electronic Prescribing systems. He led Allscripts’ IPO and secondary offerings. Under his leadership, revenues grew from $30 million in 1997 to more than $1.4 billion in 2012. Tullman stepped down in December 2012.

Prior to joining Allscripts, Tullman was CEO of Enterprise Systems, a leading healthcare-information services company providing resource-management solutions to large, integrated healthcare networks. Tullman led its IPO and secondary offerings. Enterprise was sold to McKesson HBOC (NYSE: MCK).

Tullman has founded or co-founded a number of ventures including one of the country’s leading solar energy companies, SoCore Energy, recently sold to Edison Ventures, and a digital education company, digedu, and holds investments in several ventures focused on mobile and cloud-based health solutions. A strong proponent of philanthropy, he serves as a Chancellor to the International Board of the Juvenile Diabetes Research Foundation (JDRF).

Read full bio →

Jeffrey H. Margolis

Margolis Enterprises, LLC
Chairman and CEO, Welltok, Inc.
Founding CEO and Chairman Emeritus, TriZetto

Speaker Spotlight:
Jeffrey Margolis thoughts on the HealthTech funding world.

Jeff Margolis is widely recognized as a healthcare IT entrepreneur and innovator based on his 30-year track record of successfully applying technologies to address the complex problems facing the healthcare industry. Leveraging his deep systematic understanding of healthcare and groundbreaking architectural and integration methodologies, Jeff has built some of the nation’s largest and most innovative healthcare technology and service organizations.

Jeff is currently Chairman and CEO of Welltok, Inc., where he is driving the transformation of our current sickcare system to one of optimized health. Prior to Welltok, Jeff founded TriZetto, the first industry vertical SaaS enterprise solution, and originated the concept of Integrated Healthcare Management. During his tenure as Chairman and CEO, Jeff led TriZetto through a successful IPO and $1.4B private equity buyout.

Jeff currently serves as a member of the board of directors for Quality Systems, Inc. (NASDAQ:QSII), Predilytics and Alignment Healthcare. Jeff also serves the national and local communities on the boards of several prominent non-profit and for profit organizations, including the Crohn’s & Colitis Foundation of America, Hoag Hospital in Newport Beach and the University of California at Irvine Center for Health Care Management & Policy. As a health futurist and visionary, Jeff is a frequent speaker, guest lecturer and author of two books, including The Healthcare Cure. Jeff is an alumnus of the University of Illinois and holds certified public accountant certificates in Colorado and Illinois.

Read full bio →


What are the unmet needs of Providers?

Amir Dan Rubin

President & CEO, Stanford Health Care

Amir Dan Rubin serves as President and CEO of Stanford Health Care, which seeks to serve humanity through science and compassion, one patient at a time, through its commitment to care, educate, and discover. With an operating budget of $2.7 Billion and an affiliation with Stanford University, Stanford Health Care provides leading edge and coordinated care across its growing healthcare system.

APrior to Stanford, Amir served as Chief Operating Officer for the UCLA Health System, responsible for the operations of the Ronald Reagan UCLA Medical Center, Mattel Children's Hospital at UCLA, the Resnick Neuropsychiatric Hospital at UCLA, Santa Monica-UCLA Medical Center and Orthopedic Hospital, and an array of outpatient centers across the west side of Los Angeles. Prior to UCLA, Amir has served as Chief Operating Officer for Stony Brook University Hospital in New York, as Assistant Vice President of Operations for Memorial Hermann Hospital in Texas, and as Director of Business Development for Memorial Hermann Healthcare System in Texas. Amir also previously worked as a healthcare management consultant with APM in San Francisco.

Amir currently serves on the board of directors of the University HealthSystem Consortium (UHC), the American Association of Medical College’s (AAMC’s) Council of Teaching Hospitals (COTH), the National Center for Healthcare Leadership, and The Joint Commission’s Leadership Advisory Council. He has been a frequent guest lecturer and presenter on health care strategy, lean operations, and customer service at Stanford’s Graduate School of Business and School of Medicine, UCLA’s Graduate Schools of Business and Public Health, and many other organizations.

Amir earned a Master’s degree in Business Administration and a Master’s degree in Health Services Administration from the University of Michigan, and a Bachelor’s degree in Economics with a minor in Business Administration from the University of California, Berkeley.

Read full bio →

Rich Roth

Chief Strategic Innovation Officer, Dignity Health

Rich Roth leads Dignity Health's innovation efforts, which seek to create and test novel services, programs, partnerships, and/or technologies – from within and outside of healthcare – that challenge the status quo and have the potential to reduce the cost of care, improve quality, and/or increase access to services. Working in concert with Dignity Health employees and physicians, Roth works to anticipate emerging trends and technologies with the goal of incubating, studying, and scaling efforts to improve care. Dignity Health's current focus is in the areas of mobile care and sensor based technology. Roth holds a Master's degree in Healthcare Administration from the University of Minnesota and a Bachelors degree in Public Health from West Chester University. He regularly advises venture capital organizations, and is on the Board of Ascension Health Ventures. In 2012, he was recognized by CHAUSA as one of the most promising leaders under 40 in healthcare.

Molly Coye

Social Entrepreneur in Residence Network for Excellence in Health Innovation/NEHI

Dr. Molly Joel Coye is Social Entrepreneur in Residence for the Network for Excellence in Health Innovation (NEHI), a nonprofit national health policy institute focused on enabling innovations that provide solutions to the most pressing issues facing our health care system today. From 2010 – 2015, Dr. Coye was the Chief Innovation Officer for UCLA Health and headed the Institute for Innovation in Health and the Global Lab for Innovation at UCLA, where she led the health system in identifying new strategies, technologies, products and services to support the large-scale transformation of healthcare. Today the Global Lab for Innovation advances the exchange of health delivery innovations that enable dramatic improvements in access to and affordability of health services. Dr. Coye also advises technology developers, investors, national health systems and policy makers about disruptive technologies and business models that accelerate transformation and constrain health expenditures.

Dr. Coye was previously the founder and CEO of the Health Technology Center (HealthTech), a non-profit education and research organization established in 2000 that became the premier forecasting organization for emerging technologies in health care. Dr. Coye has also served as Commissioner of Health for the State of New Jersey, Director of the California State Department of Health Services, and Head of the Division of Public Health Practice at the Johns Hopkins School of Hygiene and Public Health. Dr. Coye is an elected member of the Institute of Medicine, and a member of the Board of Directors of Aetna, Inc., Prosetta Biosciences, Inc., Big White Wall, and ACCESS Health International. She has previously served as Chair of the Board of Directors of PATH, one of the largest nonprofit organizations in global health, and on the boards of the American Hospital Association, the American Public Health Association, the American Telemedicine Association, Cholestech, Inc., The California Endowment, and the China Medical Board, as well as the advisory boards of venture and private equity firms investing in healthcare information technology and services. Dr. Coye holds M.D. and M.P.H. degrees from Johns Hopkins University and an MA in Chinese History from Stanford University, and is the author of two books on China.

Read full bio →


How are Employers driving healthcare changes?

Kyu Rhee, MD, MPP

Chief Health Officer and Vice President, IBM Corporation

Dr. Rhee serves as Chief Health Officer and Vice President of IBM, where he has direct global responsibilities for all IBM integrated health services strategy, design and operations, which include key support and leadership of business development and corporate citizenship opportunities in health and healthcare. Prior to joining IBM, Dr. Rhee was Chief Public Health Officer at the Health Resources and Services Administration (HRSA), which is the primary federal agency for improving access to health care services for people who are uninsured, isolated, or medically vulnerable. While at HRSA, he served on and led numerous national initiatives related to prevention, quality, and public health. Dr. Rhee also served as the Director of the Office of Innovation and Program Coordination at the National Institutes of Health (NIH), which is the primary federal agency for research. While at NIH, he served on and led numerous initiatives related to eliminating health disparities and promoting health equity.

Prior to his federal government service, he worked in community health settings as the Chief Medical Officer of Baltimore Medical System Inc., the largest network of Federally Qualified Health Centers in Maryland. In addition, Dr. Rhee served five years as a National Health Service Corps Scholar and Medical Director at Upper Cardozo Health Center, the largest community health center in Washington, DC. During that time, he taught at the George Washington University School of Public Health, where he received a “Best Teacher” award for his class in Community Health Leadership.

Dr. Rhee received double-board certification in both internal medicine and pediatrics. He obtained his medical degree from the University of Southern California. He did his residency and served as a Chief Resident in internal medicine and pediatrics at Cedars-Sinai Medical Center in Los Angeles. Dr. Rhee also holds a master's degree in public policy from the John F. Kennedy School of Government, Harvard University with a concentration in Health Care Policy. He acquired his bachelor's degree from Yale University in Molecular Biophysics and Biochemistry, where he also served as President of the study body.

In addition to his service on various public and private sector committees and boards, including those sponsored by the Institute of Medicine, Agency for Healthcare Research and Quality, the Robert Wood Johnson Foundation, the Clinton Foundation, the National Quality Forum, and the National Business Group on Health, Dr. Rhee speaks frequently and has published in numerous peer-reviewed journals, including American Family Physician, Pediatric Annals, Journal of Health Care for the Poor and Underserved, and the American Journal of Public Health.

Read full bio →

Lawrence "Rusty" Hofmann, MD

Co-Founder, Grand Rounds
Professor and Chief, Interventional Radiology, Stanford University

Dr. Rusty Hofmann, from Stanford Health, co-founded Grand Rounds with the goal of ensuring access to state-of-the-art care to everyone, everywhere. A few years ago, his son, Grady, became extremely ill and almost died. Dr. Hofmann was able to get an expert opinion from the country’s leading pediatric gastroenterologists on Grady’s diagnosis and treatment, which ultimately saved his life. With his “insider status,” Dr. Hofmann had access to the world’s greatest medical minds. Founded in 2011, Grand Rounds was born out of Dr. Hofmann’s vision to make all health care consumers “medical insiders.” The Grand Rounds solution helps restore individual health and quality of life, and benefits employers by facilitating decreased health care cost and increased employee productivity.

Through an employer health benefit, Grand Rounds pairs patients with the physicians experts most uniquely qualified to help them, nationally and/or locally. Chiefs, chairs and clinical experts from 115 leading institutions are available for remote patient access on the Grand Rounds platform. Of the roughly 770,000 active U.S. physicians, 96 percent have been rated by the Grand Rounds quality algorithm to help guide patients to top-quality local care. With coverage in more than 120 countries, over 50 leading companies are putting Grand Rounds’ expertise and technology to work in granting their employees an all-access pass to the best in American medicine.

Read full bio →

Brian J. Marcotte

President and CEO, National Business Group on Health

Brian is president and CEO of the National Business Group on Health, the nation's only non-profit organization devoted exclusively to representing large employers' perspective on national health policy issues and helping companies optimize business performance through health improvement and health care management. The Business Group leads initiatives to address the most relevant health care issues facing employers today and enables human resource and benefit leaders to learn, share and leverage best practices for improving health and controlling health care costs from the most progressive companies. Business Group members, which include 71 Fortune 100 companies and 426 companies in total, provide health coverage for more than 50 million U.S. workers, retirees and their families.

Previously Brian was vice president of compensation and benefits at Honeywell International; a $38B diversified manufacturing and technology company with 130,000 employees in over 100 countries. He was responsible for the strategy, design and implementation of global total rewards, executive compensation and the HR mergers and acquisitions process.

Brian joined Honeywell (formally AlliedSignal) in July of 1993 as director, group insurance programs in corporate human resources. He held various corporate and business positions at Honeywell including, vice president of benefits, corporate director of health care strategy and director of benefits for the Performance Materials & Technology business before becoming vice president of compensation and benefits in 2002.

Under Brian’s leadership, Honeywell was an early adopter of many leading-edge health cost management, employee engagement and incentive strategies including the implementation of medical and surgical decision support services and the rollout of a full-replacement consumer-directed health plan and supporting tools and resources.

In a recent Towers Watson study of over 400 large employers, Honeywell ranked in the top 10th percentile for health plan efficiency.

Prior to joining Honeywell, Brian managed Marriott International’s health care programs where he led the effort to implement one of the first nation-wide manage care programs. He also worked as a consultant for Health Management Strategies in Washington, DC and as a graduate assistant for two years with Blue Cross of Northern Ohio. He had served on the board of the National Business Group on Health for 12 years.

Read full bio →


Is digital Mental Health finally here?

Ravi Hariprasad, MD, MPH

Founder, Intuitive Consulting

Speaker Spotlight:
Ravi Hariprasad. Is Digital Mental Health Finally Here

As a board-certified, Harvard-educated physician, Dr. Hariprasad is a rare psychiatrist with a foundation in engineering and technology innovation. With an entrepreneurial background and practical experience on the bleeding edge of data science, he understands both the need and challenge present in optimizing clinical workflows with technology. Before earning a Doctorate of Medicine from the University of Pennsylvania and a Master of Public Health from Harvard University, Dr. Hariprasad attained a Bachelor of Science in Operations Research Engineering from Cornell University. In addition, Dr. Hariprasad completed his Psychiatry Residency at Massachusetts General Hospital, Harvard Medical School’s flagship teaching hospital.

Prior to launching his own practice and consultancy, Dr, Hariprasad worked as the Head of Clinical programs for Ginger.io and also served as a both a clinical and administrative leader with Kaiser Permanente Northern California. In this role he worked directly with patients, trained medical students and residents, and made significant contributions as a member of the Regional Mental Health Technology Committee. With expertise in evidence-based Western medicine and the holistic, complementary perspectives available from Vedic wisdom and Ayurvedic medicine, Dr. Hariprasad is a seasoned clinician who designs personalized strategies to help patients make lasting changes and flourish mentally, physically, and emotionally.

Bringing together the macro view of health care delivery with the micro view of individual patient care, his current consulting practice focuses on innovations in mental health care delivery systems including collaborative care, digital health, practice management, and executive coaching

Read full bio →

Eve Phillips

CEO, Empower Interactive, Inc.

Eve is the CEO & Co-Founder of Empower Interactive, Inc., a leader in digital behavioral health solutions. She is an experienced Silicon Valley product builder, entrepreneur and investor with expertise in assembling diverse teams to solve hard problems. Eve started her career as a product manager at Trilogy, an enterprise e-commerce software company, working on new ventures. From there, Eve held product, strategy and business development roles in software and internet businesses including Microsoft, Zazzle and eCert. Eve has also been a member of the investment teams at Amadeus Capital Partners, Vector Capital, and Greylock Partners. Prior to co-founding Empower, Eve was a Research Affiliate in the Synthetic Neurobiology Group at the MIT Media Lab. Eve holds an MBA from Stanford University and an SB and an M.Eng in Computer Science from the Massachusetts Institute of Technology.

Seth Feuerstein, MD

Chief Innovation Officer, Magellan Health

Seth Feuerstein is a psychiatrist, entrepreneur and technology executive responsible for driving technology innovation within Magellan’s computerized cognitive behavioral therapy platform and programs. This portfolio is the leading behavioral change and engagement software suite used by millions of individuals throughout the U.S., U.K. and other health systems. Awarded the TripleTree iAward for Connected Health in the area of “Clinical Effectiveness,” this software was developed by Feuerstein’s team at Cobalt Therapeutics, a company he started and where he served as CEO until the company was acquired by Magellan in 2014.

He also uses information technology in community service areas and founded a non-profit called Little Wonder, which improves the daily experience of cancer patients in treatment and helps patients and their loved ones create meaningful, powerful experiences together. His program has won several awards and has rapidly expanded to now serve 20 cancer centers.

He holds medical and law degrees from New York University and completed his clinical training in psychiatry at the Yale University School of Medicine in New Haven, Conn., where he is a member of the clinical faculty.

Read full bio →

Alon Matas

Founder, BetterHelp

Alon Matas founded BetterHelp, the world's largest e-counseling platform. With BetterHelp, anyone facing life's challenges can have an easy, affordable, and private access to a licensed and certified therapist. BetterHelp's members get professional counseling using their computer, tablet or mobile phone, anytime they need, anywhere they are. In 2015 BetterHelp was acquired by Teladoc (NYSE: TDOC), the nation's first and largest telehealth provider.

Prior to BetterHelp, Alon was the Founder and CEO of three startups in the consumer web space, leading them through their entire life cycles: conceptualizing, planning, fundraising, team building, product design, development, launch, iteration, commercialization, optimization, growth, and eventually M&A.

Alon is an advocate, advisor and mentor for ventures and ideas that use tech-based innovations to improve quality of life.


How Medical Image Exchange Impacted Mayo Clinic workflows

Morris Panner


Morris is an active voice in enterprise and cloud software focused on the services and healthcare verticals. He has served as the Chair of the Software and Information Industry Association and is a frequent contributor to business, healthcare and technology forums and publications including Forbes, Washington Post, HITECH Answers, and Becker’s Hospital Review. Morris has a BA from Yale University and a JD from Harvard. Prior to DICOM Grid, Morris built and sold an industry-leading business process software company, OpenAir, to NetSuite (NYSE:N). Today, Morris leads DICOM Grid in its mission to build the next generation diagnostic imaging platform and enable higher quality, more cost effective healthcare.

Jeremy Friese, MD

Medical Director, Associate Chair Radiology, Mayo Clinic

Dr. Friese is an interventional radiologist at Mayo Clinic in Rochester, Minnesota. His clinical and research focus includes minimally invasive vascular disease and cancer. He serves as Medical Director for New Ventures and Business Development in the Center for Individualized Medicine and as Associate Chair of Finance in the Department of Radiology. He is past chair of Novation’s imaging council and currently sits on the cardiovascular council. Dr. Friese is co-founder of Evidentia Health (a seed-stage HIT company), an active angel investor, and board member for SV Biosystems, Inc. He earned an M.D. from Mayo Medical School and an M.B.A. from Harvard Business School where he collaborated with Professors Clay Christensen and Michael Porter.


How will Value Based Care change healthcare delivery?

David Sayen

Regional administrator, Centers for Medicare & Medicaid Services

David Sayen assumed the position of Regional Administrator of the Centers for Medicare & Medicaid Services, Region IX in February 2008. David is based in San Francisco, and his jurisdiction includes California, Arizona, Nevada, Hawaii, and the Pacific Territories. He replaces Acting Regional Administrator Charlotte Yeh, who is returning to her regular duties as Regional Administrator of the New England region of CMS.

David brings more than 29 years of Federal service and experience in health and human services programs to the position of Regional Administrator. Since 2002, he has served as Associate Regional Administrator for the Division of Medicare Health Plans Operations, leading all private health plan contract operations for Medicare Advantage and the Medicare Prescription Drug benefit in Region IX. From 1999 to 2002, he was the Associate Regional Administrator for the Division of Medicare Financial Management, where he ran the Medicare Contractor Financial Management and Program Integrity functions.

From 1998 to 1999, David led a team charged with ensuring that 11 Medicare claims processors successfully prepared for Y2K. From 1994 to 1998, he directed all Medicare managed care and fee-for-service customer service operations as Branch Chief, Medicare Managed Care Branch, in the Philadelphia Regional Office of CMS.

In 2003 David was named a Senior Fellow of the Council on Excellence in Government Fellowship, and he is also a member of the Adaptive Business Leaders Healthcare Roundtable of Northern California. He earned a bachelor’s degree in philosophy from Temple University, Philadelphia, PA in 1977 and an MBA with an emphasis on health administration from Temple University in 1991.

David lives with his family in Alameda, CA.

Read full bio →

Jeffrey Rideout, M.D., M.A., FACP

President and CEO, the Integrated Healthcare Association
Senior Advisor, GE Ventures
Consulting Professor, Stanford University, Health Research and Policy
Lecturer, University of California Berkeley, Haas School of Business

Dr. Rideout was recently appointed as President and CEO of the Integrated Healthcare Association. The Integrated Healthcare Association is a California statewide multi-stakeholder leadership group that promotes quality improvement, accountability and affordability of health care. Dr. Rideout also serves as a Senior Advisor to GE Ventures, focusing on new business development related to Digital Health and Digital Therapeutics, including assessing and accelerating new early stage solutions and companies. Dr. Rideout holds academic appointments with Stanford University and University of California Berkeley Haas School of Business, teaching on topics related to healthcare technology, services and investment.

Previously Dr. Rideout served as the Senior Medical Advisor for Covered California, the state based insurance exchange for California. Together with Medi-Cal expansion, the state of California reduced the number of uninsured in California by 50% in its first year. In this role Dr. Rideout was responsible for quality and network management and all physician and hospital relations. Previously Dr. Rideout was SVP, Chief Medical Officer for The TriZetto Group, leading strategy around development and delivery of a comprehensive suite of products and services that enable payers, providers and employers improve the cost and quality of care for consumers. Dr. Rideout also served as the global leader of the healthcare division for Cisco Systems Internet Business Solutions Group, and Cisco’s Chief Medical Officer, working with health care and public sector leaders to help them use technology to accelerate transformation of the health care industry, and also provided strategic leadership for health benefit value purchasing decisions for Cisco’s 65,000 employees and dependents worldwide. While at Cisco, Dr. Rideout also served as a member of the American Health Information Community (AHIC’s) Chronic Care Workgroup for the US Department of Health and Human Services.

Prior to Cisco, Dr. Rideout was Chief Medical Officer and SVP for Blue Shield of California and head of Quality Management for Blue Cross of California/WellPoint. Dr. Rideout served as a member of the National Advisory Council for the Robert Wood Johnson/IHI Pursuing Perfection grant program for excellence in health care delivery, and also served as the Chief Medical Officer for the National Health Care Purchasing Institute. Dr. Rideout is currently on the board of Contra Costa Interfaith Housing, which provides permanent housing to low income families in the Contra Costa County in California.

Dr. Rideout completed his residency training in internal medicine at University of California, San Francisco and is a Fellow of the American College of Physicians. He received his medical degree from Harvard Medical School and his undergraduate degree from Stanford University. He also holds a master’s degree in Philosophy, Politics, and Economics from Oxford University where he studied as a Rhodes Scholar.

Read full bio →

Sam Glick

Partner, Oliver Wyman

Sam Glick is a Partner in Oliver Wyman’s Health and Life Sciences practice, and the San Francisco Office Leader. He focuses on consumer-centric healthcare, working with leading providers, health plans, employers, enablement companies, retailers, and venture capital firms to find innovative, engaging ways to bend trend. He is an author of several recent Oliver Wyman points of view, including A Billion-Dollar Decision: Charting a New Course for US Healthcare Benefits and Private Exchanges Change the Game. Sam also leads many of Oliver Wyman’s healthcare commercialization research and intellectual capital development efforts.

Sam has been invited to speak at a number of events for healthcare senior executives and board members, including the American Hospital Association (AHA) Leadership Summit, the AHA Center for Healthcare Governance Symposium, the Council on Employee Benefits Annual Conference, the Accountable Care Congress, the Integrated Healthcare Association annual board retreat, the CAPG Healthcare Conference, the Leadership Institute roundtable, and the UnitedHealth Group Smart Circle series. He is quoted regularly in both the industry and popular press.

Previously, Sam was in the high-tech strategy practice at Accenture. Prior to that, he led global business strategy, new offer development, merger, acquisition, and divestiture activities at Mercer. He also spent six years as the founder and chief executive of Algebra Online, a web-based educational services business.

Sam received his BA with honors in economics from Pomona College, and was a Rotary Ambassadorial Scholar and North American Postgraduate Scholar in the MSc program in economics at the University of Warwick. He chairs the Pomona College Board of Trustees. Sam lives in San Francisco with his wife, Emily.

Read full bio →

Dr. Thomas J. Van Gilder, MD, JD, MPH

Chief Medical Officer and Vice President of Informatics and Analytics

Thomas J. Van Gilder, MD, JD, MPH, chief medical officer and vice president of informatics and analytics, is a board-certified physician in internal medicine, general preventive medicine and public health. Prior to joining Transcend Insights, he held several positions at Humana including a position as the national medical director for wellness.

Before Humana, Dr. Van Gilder served as the medical director for quality initiatives and as a practicing primary care physician for QuadMed, an organization that directs on-site medical facilities for a number of companies. He also served over nine years in the U.S. Public Health Service at the Centers for Disease Control and Prevention.

In addition, Dr. Van Gilder is an attorney specializing in intellectual property. He has spoken nationally and internationally on a variety of law, public health and healthcare topics including primary care transformation, value-based benefit design and on-site clinical care.

Dr. Van Gilder obtained a master’s degree in public health from the Harvard School of Public Health.

Read full bio →


Automating charting and physician notes with smart glasses

Ian Shakil

CEO and co-founder, Augmedix

Ian is the CEO and co-founder of Augmedix. He's always been passionate about the intersection of science, engineering, and medicine which drew him to study Biomedical Engineering at Duke Unversity and complete his MBA at Stanford University. Ian has worked in several lifesciences and medical companies such as Intuitive Surgical, MC10, Edwards Lifesciences, and PixelOptics. Late in the summer of 2012, Ian had the rare opportunity to try an early version of Google Glass. He was inspired by the potential that he saw for Glass in healthcare, and dropped everything to found Augmedix, the first Google Glass startup.

Teresa Nauenberg, MD

Head for primary care at the Palo Alto Medical Foundation, California

Dr. Teresa Nauenberg MD is the division head for primary care at the Palo Alto Medical Foundation in Palo Alto, California, where she has been practicing medicine for the last 15 years. She received her medical degree from the University of California, San Francisco and trained at the University of California, Davis. Prior to becoming a physician, Dr. Nauenberg worked as a mechanical engineer for Hewlett Packard. Dr. Nauenberg is married and has two children; she enjoys skiing, gardening and traveling.


How to leverage digital media to personalize patient engagement

Chris Kuenne

CEO, Rosemark capital

Chris has devoted his career to converting deep consumer insights into commercial value. He began his career in product management at Johnson & Johnson, where he rose quickly to run the $1B TYLENOL franchise, before starting his own marketing services business in 1998, called Rosetta. Chris and his team built Rosetta over the subsequent 13 years to be the largest privately held digital marketing agency in the world, before they sold it to the Publicis Groupe for a record price in 2011.

Since 2013, Chris has focused his energies on applying his commercialization skills to investing, teaching and writing a book on entrepreneurial founders. In 2014, Chris founded Rosemark Capital, a growth equity firm focused on investing in founding teams who have established product-market fit and are seeking capital and growth expertise to accelerate customer engagement, revenue and enterprise value. Rosemark specializes in the HealthTech, MarketingTech and FinTech sectors. Chris also teaches a very popular course at Princeton University on starting a high tech venture and is in the process of collaborating with one of his Princeton colleagues, John Danner, on a book devoted to understanding the role the personality of the founder plays in shaping the growth trajectory of the most successful enterprises.

Chris is a Board Member of Jiff, Sword Rowe, Princeton Day School, The New School University, The Burke Foundation and Broad Futures.

He graduated from Princeton University in 1985 with a B.A. in History and from the Harvard Business School with Honors in 1989. He lives in Princeton, NJ and Shelburne, VT with his wife Leslie and their three sons, Peter, William and Matthew.

Read full bio →

Derek Newell

CEO, Jiff, Inc.

Speaker Spotlight:
Derek Newell. Jiff CEO's View on Employers Driving Healthcare Changes

For 20 years, Derek has been leading innovative health technology and service companies. He led the company that built the first FDA-approved internet connected medical device and grew it into the world’s largest remote patient monitoring company. Before that, at LifeMasters, he helped pioneer the first patient-centric disease management platform and built one of the largest disease management companies in the US. Derek holds graduate degrees in business and public health from UC Berkeley.

Adam Jackson

CEO and co-founder, Doctor On Demand

Speaker Spotlight:
Adam Jackson's view on patient engagement personalization

Adam Jackson is a technology entrepreneur obsessed with creating beautiful and easy to use products for both mobile and desktop web interfaces.
He is currently CEO and co-founder of Doctor On Demand, a healthcare service that provides Video Visits with board-certified physicians and psychologists via smartphones, tablets, and desktop computers. Patients simply download the Doctor On Demand app on a smartphone or tablet or visit www.doctorondemand.com on their desktop computer, provide a list of their symptoms, and are instantly connected to a provider licensed in their state for a video visit. Doctor On Demand delivers services through employers, health systems, health plans, and directly to consumers.

His previous business, DriverSide (founded in 2007), served thousands of automotive dealerships and repair facilities by helping them retain existing and gain new customers through a suite of SaaS offerings. It was acquired by Advance Auto Parts (AAP) in September of 2011.

His first venture-backed business, MarketSquare (founded in 2004), was the first online local shopping destinations on the Internet. In 2005 it was acquired by StepUp Commerce, a similar service, which was subsequently acquired by Intuit (INTU) in September of 2006.

Over the past 8 years, he has also been an active angel investor and advisor to over 2 dozen companies, most of which have had successful exits or have done significant follow-on financing.

Adam began his career as a software engineer and architect and holds a computer science degree from Vanderbilt University.

Read full bio →

C. Andy Schuetz, PhD

Sr. Data Scientist, Sutter Health

C. Andy Schuetz, PhD is a Sr. Data Scientist in Sutter Health’s Research Development & Dissemination group. Prior to Sutter Health, Andy managed the early development of the Evalytica cloud-based pharmacovigilance solution for Evidera. At Archimedes, he led the development of the ARCHeS SaaS product suite that leveraged the Archimedes model to improve the quality and efficiency of healthcare. Andy has nine years of experience in the healthcare analytics and medical device space. His research has focused on improving care for patients with type 2 diabetes and cardiovascular disease. He has authored publications in high impact journals such as Health Affairs and PLOS ONE, and has spoken at conferences such as Health Datapalooza and the Society for Medical Decision Making Annual Meeting. He received his PhD and BS in mechanical engineering from the University of California at Berkeley.


Are Digital Therapeutics the next unicorns?

Alan Levy, PhD

Chairman and Chief Executive Officer, Chrono Therapeutics

Dr. Levy brings more than 30 years of senior operational leadership and experience in the medical device industry. Prior to Chrono Therapeutics, he was the founding CEO of Incline Therapeutics that was acquired by The Medicines Company in January 2013 for up to $390 million.

Previously, he was the President and CEO of Northstar Neuroscience, a company developing innovative therapies for neurological diseases and disorders. Dr. Levy also served as the CEO of Heartstream, Inc. and was the President of Heart Technology, Inc.

Dr. Levy received his Ph.D. in Organic Chemistry from Purdue University, a B.S. in Chemistry from City University of New York, and holds an Honorary Doctor of Science from Purdue University. He serves as a board member of several public and private companies including Intuitive Surgical, Proteus Digital Health and Seattle BioMed.

Read full bio →

Sean Duffy

Co-founder and CEO, Omada Health

Sean Duffy is the co-founder and CEO of Omada Health, one of Fast Company’s "50 Most Innovative Companies in the World." Omada Health is a digital health company dedicated to inspiring and empowering people everywhere to live free of chronic disease. The company’s flagship product, Prevent, is a 16-week, CDC-recognized program that lowers participants’ risk for obesity-related chronic disease using cutting-edge technology, world-class design, and the power of social networks.

An in-demand speaker and thought leader, Sean's accolades include a spot on The San Francisco Business Times’ 2015 list of "40 Under 40," J.P. Morgan's list of the "100 Most Intriguing Entrepreneurs of 2014,” and Diabetes Forecast magazine's list of "2014 Diabetes All Stars.”

Past speaking engagements include SXSW Interactive, Le Web Paris, Exponential Medicine, Stanford Medicine X, Health2.0, and the HealthTech Conference.

Sean has written enthusiastically about the future of healthcare in The Wall Street Journal, Forbes, MedGadget, and TechCrunch, among other publications.

Prior to Omada, Sean worked at both Google and IDEO. A former MD/MBA candidate at Harvard, he holds a BS in neuroscience from Columbia University."

Read full bio →

Rick Altinger

CEO, Glooko

Rick Altinger serves as Glooko’s first CEO, and brings over 15 years of industry experience in healthcare information technologies. While an executive at Intuit Health, Altinger helped launch the healthcare division’s provider services and drove Intuit’s acquisition of Medfusion in 2010. He also spearheaded Intuit Health’s growth as the leading supplier of patient-provider communication and patient portal services. His technical knowledge and expertise is central to Glooko’s diabetes healthcare platform and its goal of allowing anyone to monitor blood glucose levels regardless of meter, pump, CGM or mobile device type.


Leveraging machine learning to optimize patient flows

Mohan Giridharadas

CEO and Founder, LeanTaaS Inc.

18 years at McKinsey & Company (7 as a partner, 6 as a senior partner/director). Led the Manufacturing and Service Operations practices in the US and the Asia-Pacific region. Led large-scale operational improvement programs at major corporations across multiple sectors including healthcare, technology, retail and financial services. On the faculty of the Continuing Studies program at Stanford University and the MBA program at the Haas School of Business at UC Berkeley. Holds an MBA from Stanford University, an MS in Computer Science from Georgia Tech, and a BTech in Electrical Engineering from IIT Bombay.

Sri Seshadri, PhD

Vice President for the Cancer and Cardiovascular service lines, Stanford Health Care

Dr. Sridhar (“Sri”) Seshadri joined Stanford Health Care (SHC) in July 2003 and is currently the Vice President for the Cancer and Cardiovascular service lines. Dr. Seshadri previously oversaw the hospital’s process excellence activities and in this role was responsible for improving the patient experience and increasing operational efficiencies across the hospital and the clinics. He is also responsible for the creation of the SHC Leadership Academy whose objective is to develop a cadre of empowered leaders to help SHC achieve its long term objectives. In his current role, he is responsible for the design and implementation of coordinated complex-care delivery across two of SHC’s strategic service lines. In order to fully leverage the research and development potential in the cancer service line, Dr. Seshadri is a member of the Executive Committees of the Stanford Cancer Institute.

Until 2002, Dr. Seshadri was employed by General Electric's Medical Systems division and was most recently the Vice-President and General Manager of their Healthcare Solutions business which consulted on Six Sigma operational improvements for hospitals in the United States and Europe. Prior to General Electric he worked for the Eastman Kodak Company where he led their digital imaging business for healthcare. Dr. Seshadri started his career with the Hospital of the University of Pennsylvania where he led their Medical Informatics Group. He has a Bachelor’s degree in Electrical Engineering from Bangalore University, India, a Master’s degree in Electrical Engineering from Drexel University, a Master’s degree in Business Administration from the Wharton School at the University of Pennsylvania, and a doctorate from the Weatherhead School of Management at Case Western Reserve University.

He has published over 120 papers and two book chapters largely in the area of medical imaging informatics.

Read full bio →

Who will be the 2015 Most Promising Healthtech Company?

Jack Young

General Partner, dRx Capital AG
Senior Director, Qualcomm Ventures

Speaker Spotlight:
Jack Young thoughts on the HealthTech funding world.

Jack heads up the Qualcomm Life Fund (QLF) at Qualcomm Ventures, which was ranked as one of the most active venture investors in digital health. He is also a fund manager at dRx Capital, a Novartis and Qualcomm joint investment company. His investment interests are focused on the intersection of healthcare products and services and digital/wireless technologies. Jack’s current digital health investments include: Airstrip, AliveCor, ClearCare, Doctor On Demand, goBalto, Telcare and Welltok. Prior investments include: Validity (acquired by Synaptics), and Fitbit (NYSE: FIT).

Prior to Qualcomm Ventures, Jack was EVP and US Country Manager at ZTE who helped establish the company’s US market presence. He was a sales and marketing executive at Nokia following the acquisition of Amber Networks where he was founding AVP of marketing. Early in his career, he held marketing and business development positions at 3Com, GDC, and Nortel. Jack earned a MSEE from University of Calgary and a MBA from McGill University.

Read full bio →

Renee C. Ryan

Vice President, Venture Investments

Renee Compton Ryan, Vice President, Venture Investments, joined Johnson & Johnson Innovation - JJDC, Inc. (JJDC) in 2011. She is based in Silicon Valley, California. Mrs. Ryan's background includes over 20 years of healthcare investment banking. Most recently, she ran the medical device investment banking effort at R.W. Baird & Co.

Previously, she lead the West Coast medical device group at Jefferies & Co. and was in the healthcare investment banking groups at Goldman Sachs and Credit Suisse. Mrs. Ryan received an MBA from Columbia Business School and a Bachelors degree from Georgetown University.

Casper de Clercq

Partner, Norwest Venture Partners

With over 30 years of experience, Casper is a veteran of the medical device and life sciences industry. He brings extensive operating knowledge to Norwest Venture Partners having led marketing and commercialization efforts for cardiovascular device, specialty pharmaceutical, and diagnostic companies. Casper focuses on mid-to-late-stage investments in medical devices, specialty pharmaceuticals, healthcare services, and healthcare IT. Along with his current board seats at Intersect ENT, iRhythm Technologies, and Simpirica Spine, Casper has invested in Misfit Wearables. He was previously on the board of Basis (acquired by Intel).

Tom Rodgers

Senior Vice President and Managing Director, McKesson Ventures

Tom Rodgers is the Senior Vice President and Managing Director leading McKesson Ventures. He spent more than a decade in health care venture capital, most recently leading strategic investing efforts for Cambia Health, and before that as a Partner with Advanced Technology Ventures.

Before his venture capital career, Rodgers had significant operating experience in the health care industry. He held various strategy and commercial roles at leading technology companies such as McKesson, Genentech, FitLinxx and The Wilkerson Group.

Rodgers holds an M.B.A. from the Wharton School and a B.A. from the University of Pennsylvania. He was an All-American rugby player and long ago the math team champion of New Hampshire.

Read full bio →

October 27, 2015


Gale Richards

Partner, Bioquest

Gale Richards has built and developed senior leadership teams for fast-growing Healthcare Technology companies for over 25 years. As both a seasoned executive recruiter and a hands-on sales and marketing leader in the healthcare space, Gale knows what it takes to understand a company’s DNA and build the right teams to accomplish its mission.

As a partner at BioQuest since 2003, Gale has become an essential advisor to CEOs, board members and venture capitalists as they search for exactly the right talent for their senior leadership teams. Gale’s search experience is international and includes C-suite, board members and senior executives for every cross-functional role. Gale’s sectors of expertise include: Digital Health, Medical Devices and Diagnostics.

Prior to her career in Executive Search, Gale held executive level positions leading sales and marketing teams at Lumedx and Spacelabs Medical. During her 13-year tenure at Spacelabs, the company grew from a $25M private company to a $300M global leader in patient monitoring.

Gale is an active investor, as a member of Life Science Angels since 2008 and serves as a mentor for the Entrepreneurship Center at UCSF. Gale received her Bachelor of Science degree in Nursing from Texas Woman’s University and practiced as a registered nurse in emergency medicine.

Read full bio →

Robin Cisneros

National Director, Medical Technology Assessment and Products, The Permanente Federation

Robin Cisneros provides strategic direction and oversight of Kaiser Permanente’s new medical product and technology assessment and selection processes. For more than 25 years, Robin has been developing and leading the organization’s evidence-based, physician-led resources that assess, select, and purchase medical products and technology. This includes directing a complex, national network of clinical and business leaders, serving on several national KP initiatives, while aligning resources and clinical leadership to support large scale projects that deliver increasing value to patients and KP.

Darren Dworkin

Senior Vice President, Enterprise Information Systems;
CIO, Cedars‐Sinai Health System

Darren Dworkin is Senior Vice President of Enterprise Information Systems and Chief Information Officer of the Cedars­Sinai Health System in Los Angeles, California. Additionally, Mr. Dworkin is the co-founder of Stanson Health and a managing director of Summation Health Ventures. Mr. Dworkin has spent over 20 years in information technology and over 12 in healthcare.
At Cedars-Sinai he has led the implementation of a comprehensive electronic medical record to help transform care through the use of advanced technology. Day to day Mr. Dworkin leads the strategy and technology operations of both the information and clinical technology teams.

At Stanson Health he has helped to create a software solution to deliver real-time clinical decision support at the point of care. Stanson aims to reduce low­value and unnecessary care by leveraging real-time alerts and relevant analytics to guide and influence physician’s decisions.

At Summation Health Ventures, Mr. Dworkin leads select investments and portfolio companies aligned with Summation Health Ventures goals of providing strategic funding to privately held companies offering innovative products, services and technologies which help health care systems significantly improve performance and outcomes.

Prior to joining Cedars‐Sinai, Mr. Dworkin held the position of Chief Technology Officer at Boston University Medical Center in Boston, MA. Were he led the development and deployment of the infrastructure and application framework to bring technology to the point of care. Mr. Dworkin has been a leader helping major information technology vendors bring solutions to the healthcare vertical enabling improvements in workflow, quality and value.

Mr. Dworkin is presently on the advisory boards of The Wall Street Journal, Dell, AT&T, Philips, Avia, and Next Wave.

A native of Montreal, Canada, Mr. Dworkin lives in Los Angeles with his wife and two daughters.

Read full bio →

Wende Hutton

Managing Director, Canaan Partners

Healthcare investor Wende Hutton brings 20 years of experience to identifying, investing in and building companies that are changing the practice of medicine. She has facilitated bringing over a dozen medical devices and drugs to market, and currently sits on the boards of Aldea Pharmaceuticals, Butterfly Health, Chimerix (CMRX), Dermira, Labrys Biologics, ReVision Optics, Theraclone Sciences and Transcend Medical.

Wende joined Canaan in 2004, and her life sciences track record includes 6 IPOs and 4 acquisitions. She began her venture career at Mayfield Fund in 1993, where she worked closely with the founding teams of Heartstream (HPQ) and Northstar Neuroscience (NSTR). Earlier in her career, Wende held senior operational management positions at GenPharm International and Nellcor. Wende holds an AB in human biology from Stanford University and an MBA from Harvard Business School, where she was a Baker Scholar.

Read full bio →

Noah Lewis

Managing Director, GE Ventures

Noah Lewis specializes in healthcare IT, digital health, clinical services and medtech investments across high growth company lifecycle stages—from series A to growth equity. His investing focuses on solutions that enable the transition to value-based care, dramatically reduce health system costs and improve patient outcomes. Prior to entering venture capital, Noah led corporate strategy for the $10B GE Healthcare Systems division where he previously led growth-focused marketing and product management initiatives. Noah started his 20 year operating career in the technology industry at IBM where he pioneered SaaS, cloud computing and e-commerce solutions. Noah holds a Masters degree from MIT and a Bachelors of Science degree from Skidmore College.

Joel Krikston

Managing Director, Merck Global Health Innovation Fund

Joel Krikston is a Managing Director with Merck’s Global Health Innovation Fund, LLC (“GHI”). Joel is focused on identifying new investment opportunities in Health Information Technology and Technology Enabled Solutions with an emphasis on Decision Support, Accountable Care and Population Health. Joel is currently on the Board of MedCPU, Inc., is a Board Observer at Electrocore, LLC and is GHI’s representative to the New York Digital Health Accelerator.

Mr. Krikston has over 20 years of experience in healthcare innovation. Prior to joining Merck GHI in 2013, he was an Investment Principal at Johnson & Johnson Development Corporation, leading the group’s efforts in healthcare technology and diagnostics while also supporting medical devices and pharmaceuticals. He has previously served on the Boards of GetWellNetwork (acquired by Welsh Carson in 2012) and Imacor. During Mr. Krikston’s seven years with J&J, he served in a range of business development roles at both the corporate and operating company level focused on the identification, formation, development and launch of new businesses in emergent healthcare segments.

Prior to joining Johnson & Johnson, Joel spent over eight years as an investment banker, covering an array of healthcare clients and included experience at BNP Paribas, JPMorgan and ABN Amro. Joel has an MBA with honors from the Stern School of Business at NYU and completed his Bachelor’s degree in Finance and International Business at Fairfield University.

Read full bio →

Seth Frazier

Chief Transformation Officer, Evolent Health

Seth oversees Evolent Health’s client transformation practice. He most recently served as the Chief Transformation Officer for the Geisinger Health System prior to joining Evolent. His responsibilities included providing business leadership to large-scale innovation projects within the health system (e.g., Geisinger Accelerated Performance Program) and external consulting for Geisinger Ventures. Prior to Geisinger, Seth was Senior Vice President, Strategic Services for The Children’s Hospital of Philadelphia (CHOP). Seth led CHOP’s proton therapy development initiative, national contracting for tertiary services and strategic plan development and management. Before assuming the strategic services role, Seth had executive responsibilities for CHOP-affiliated Children’s Health Net, a pediatric managed care organization that developed and managed a globally capitated 100+ PCP network under contract with the dominant regional HMO. Seth came to CHOP after a 9-year consulting career with a large national health care firm. His practice areas included clinical resource management, managed care, service line strategy, hospital redesign and strategy.

David B. Klein

Co‐Founder & CEO, Click Therapeutics, Inc.

David Benshoof Klein is a healthcare investor and entrepreneur with over 14 years life science industry experience; he has played key roles in founding, financing and developing more than 10 life science companies. In 2012, Mr. Klein co­founded Click Therapeutics which focuses on engineering, validating and commercializing Digital Therapeutics™ applications to benefit people with brain disorders and neuropsychiatric dysfunction. He formerly served as Managing Director at a life science asset management firm, senior consultant to Pfizer, and strategic advisor to numerous publicly traded and privately held life science companies. Mr. Klein is an avid art enthusiast and is co‐founder and owner of Klein Sun Gallery, America’s leading Chinese contemporary art gallery with locations in New York’s Chelsea art district and Beijing, China. A native New Yorker, Mr. Klein has been a guest lecturer at Columbia University’s Biotechnology Program, and holds a B.A. from Brandeis University.

Ian Edvalson

Partner, Wilson Sonsini Goodrich & Rosatis

Ian Edvalson is a partner in Wilson Sonsini Goodrich & Rosati's Palo Alto and San Diego offices. He assists private and public companies in creating and implementing strategies to optimize their technology and other assets, advising them on a variety of legal and business issues. Ian represents clients in domestic and international transactions involving intellectual property or product rights, such as collaboration, development, manufacture, supply and distribution agreements, technology acquisitions, university licenses, and the formation of joint ventures and other types of strategic alliances. Ian has a wide variety of business and legal experience covering a full range of issues and transactions facing technology companies, particularly in the biopharmaceutical and life sciences industries. He works closely with his clients in setting strategic direction and structuring and negotiating mission-critical business arrangements.

Prior to rejoining the firm in 2002, Ian was senior vice president of corporate and business development at Third Wave Technologies, Inc., where he was responsible for implementing and managing its product development and licensing strategies for both research and clinical markets. Additionally, he played a significant role in Third Wave's financing strategy (including its February 2001 IPO) and developing and maintaining significant customer and collaborator relationships. Because of Ian's company-based experience, he is particularly attuned to issues faced by emerging company clients. Ian received his J.D. degree from the University of Chicago Law School and his B.S. & B.A. degree in Molecular Biology & Korean from Brigham Young University. He is admitted to practice in California.

Read full bio →

Kit Sun

Founder and CEO, NavisHealth

Kit Sun is the Founder and CEO of NavisHealth, and is responsible for the company’s day-to-day operations. Sun oversaw the growth of the company since the inception and has led the successful launch of the company’s flagship healthcare analytics products and the mobile patient engagement solutions. Prior to NavisHealth, Sun served as a management consultant specialized in Health IT operations in the Provider industry. Previously, Sun spent 7 years at Autodesk where he held multiple management roles including International business development, Emerging product management and SaaS business operations. Sun holds a Bachelor of Science degree in Electrical and Computer Engineering from University of Wisconsin, Madison.

Murray Brozinsky

Chief Strategy Officer, Healthline Networks

As chief strategy officer for Healthline Networks, Murray Brozinsky heads business and corporate development for the company – including its consumer subsidiary, Healthline.com, and its enterprise technology subsidiary, Talix. He has more than 20 years of experience founding, operating and advising high growth technology firms. Murray has spoken at numerous industry conferences on various health information technology topics and trends. He holds a B.S. in Finance and a B.A. in Philosophy from the University of Pennsylvania, an M.S. in Engineering from Northwestern University’s McCormick School of Engineering and Applied Science, as well as an M.B.A. from Northwestern University's Kellogg and McCormick schools. Murray also sits on the board and/or advisory board of numerous tech start-ups.

Sign up and get tickets
for $1,295